21614153

Source:http://linkedlifedata.com/resource/pubmed/id/21614153

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0011900, umls-concept:C0030705, umls-concept:C0040223, umls-concept:C0079611, umls-concept:C0079613, umls-concept:C0441833, umls-concept:C2931822
pubmed:issue	5
pubmed:dateCreated	2011-5-26
pubmed:abstractText	Adoptive immunotherapy with EBV-specific CTLs (EBV-CTL) has been used to treat EBV-associated nasopharyngeal carcinoma (NPC) but only a fraction of the patients shows noticeable clinical response.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/21614153-10925292, http://linkedlifedata.com/resource/pubmed/commentcorrection/21614153-11018123, http://linkedlifedata.com/resource/pubmed/commentcorrection/21614153-11408795, http://linkedlifedata.com/resource/pubmed/commentcorrection/21614153-11507075, http://linkedlifedata.com/resource/pubmed/commentcorrection/21614153-12450729, http://linkedlifedata.com/resource/pubmed/commentcorrection/21614153-12460912, http://linkedlifedata.com/resource/pubmed/commentcorrection/21614153-12467964, http://linkedlifedata.com/resource/pubmed/commentcorrection/21614153-12472179, http://linkedlifedata.com/resource/pubmed/commentcorrection/21614153-12763937, http://linkedlifedata.com/resource/pubmed/commentcorrection/21614153-1377517, http://linkedlifedata.com/resource/pubmed/commentcorrection/21614153-15022282, http://linkedlifedata.com/resource/pubmed/commentcorrection/21614153-15076135, http://linkedlifedata.com/resource/pubmed/commentcorrection/21614153-15370241, http://linkedlifedata.com/resource/pubmed/commentcorrection/21614153-15542583, http://linkedlifedata.com/resource/pubmed/commentcorrection/21614153-15798092, http://linkedlifedata.com/resource/pubmed/commentcorrection/21614153-15813855, http://linkedlifedata.com/resource/pubmed/commentcorrection/21614153-16153856, http://linkedlifedata.com/resource/pubmed/commentcorrection/21614153-16204009, http://linkedlifedata.com/resource/pubmed/commentcorrection/21614153-16304390, http://linkedlifedata.com/resource/pubmed/commentcorrection/21614153-16720343, http://linkedlifedata.com/resource/pubmed/commentcorrection/21614153-16967292, http://linkedlifedata.com/resource/pubmed/commentcorrection/21614153-17031467, http://linkedlifedata.com/resource/pubmed/commentcorrection/21614153-17049016, http://linkedlifedata.com/resource/pubmed/commentcorrection/21614153-17609424, http://linkedlifedata.com/resource/pubmed/commentcorrection/21614153-17987110, http://linkedlifedata.com/resource/pubmed/commentcorrection/21614153-18087217, http://linkedlifedata.com/resource/pubmed/commentcorrection/21614153-18540829, http://linkedlifedata.com/resource/pubmed/commentcorrection/21614153-18694349, http://linkedlifedata.com/resource/pubmed/commentcorrection/21614153-18971421, http://linkedlifedata.com/resource/pubmed/commentcorrection/21614153-19880495, http://linkedlifedata.com/resource/pubmed/commentcorrection/21614153-20013806, http://linkedlifedata.com/resource/pubmed/commentcorrection/21614153-20064222, http://linkedlifedata.com/resource/pubmed/commentcorrection/21614153-4546189, http://linkedlifedata.com/resource/pubmed/commentcorrection/21614153-8302707, http://linkedlifedata.com/resource/pubmed/commentcorrection/21614153-8946604, http://linkedlifedata.com/resource/pubmed/commentcorrection/21614153-9704488
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/101235568
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Cytokines, http://linkedlifedata.com/resource/pubmed/chemical/EBV-associated membrane antigen..., http://linkedlifedata.com/resource/pubmed/chemical/Viral Matrix Proteins
pubmed:status	MEDLINE
pubmed:issn	1449-2288
pubmed:author	pubmed-author:ChenQiu-yanQY, pubmed-author:HuangZhou-fengZF, pubmed-author:JidahJJ, pubmed-author:MoHaoyuanH, pubmed-author:ZengYi-xinYX, pubmed-author:ZhangYi-lanYL
pubmed:issnType	Electronic
pubmed:volume	7
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	607-17
pubmed:meshHeading	pubmed-meshheading:21614153-Carcinoma, pubmed-meshheading:21614153-Cells, Cultured, pubmed-meshheading:21614153-Cytokines, pubmed-meshheading:21614153-Female, pubmed-meshheading:21614153-Herpesvirus 4, Human, pubmed-meshheading:21614153-Humans, pubmed-meshheading:21614153-Immunophenotyping, pubmed-meshheading:21614153-Immunotherapy, Adoptive, pubmed-meshheading:21614153-Leukocytes, Mononuclear, pubmed-meshheading:21614153-Lymphocyte Activation, pubmed-meshheading:21614153-Male, pubmed-meshheading:21614153-Middle Aged, pubmed-meshheading:21614153-Nasopharyngeal Neoplasms, pubmed-meshheading:21614153-T-Lymphocytes, Cytotoxic, pubmed-meshheading:21614153-Viral Matrix Proteins
pubmed:year	2011
pubmed:articleTitle	Immunophenotyping at the time of diagnosis distinguishes two groups of nasopharyngeal carcinoma patients: implications for adoptive immunotherapy.
pubmed:affiliation	State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China.
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't